IDNLS: A Robust Development Of Multiple Sclerosis Segmentation And Classification Methodology Using Intelligent Deep Neural Learning Scheme

One of the most important ways to diagnose Multiple Sclerosis (MS) and track the disease's course is via magnetic resonance imaging. There have been some efforts to use AI to segment MS lesions, but completely automated analysis is still not accessible. This article presents an experimental investigation of the process of MS classification and segmentation using Magnetic Resonance Imaging (MRI). Identifying the quantity of experimental lesions allows for exact tracking of lesion growth level, which in turn allows for correct assessment of pharmacological effects in medical tests, and therefore knowledge of MS lesions. Because MS lesions can change size and shape over time and aren't always easy to spot in different people's anatomy, accurately identifying them in MRI scans is an extra challenging task. An innovative deep learning technique, Intelligent Deep Neural Learning Scheme (IDNLS), was presented in this study. To test how well it performs, it was cross-validated with an existing model, Convolutional Neural Network (CNN). Accurate segmentation can tell you this; manually segmenting it would be a huge pain due to the high degree of expertise required and the extra time it would take. Automated lesion segmentation requires the determination of inter- and intra-expert variability. In addition, we went over the pros and cons of using AI in MS diagnosis, so that researchers and practitioners may refine their methods and make automated MS diagnoses more accurate. Some of the problems with automated multiple sclerosis diagnosis include: collecting a big enough reliable dataset; keeping patients' data private; developing ML models that are both accurate and easy to understand for those without medical training; and finally, the difficulty of differentiating MS from other diseases that present similar symptoms.